IL-23 Inhibitors Linked to Lower PsA Risk in Psoriasis Study



A comparative analysis identifies the top IL-23 inhibitors that were least likely to be associated with the development of psoriatic arthritis in patients with psoriasis.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/il-23-inhibitors-linked-lower-3-year-psoriatic-arthritis-2026a1000eur?src=rss

Author :

Publish date : 2026-05-08 10:34:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version